Top news of the week: 01.03.2022.
Healthcare
UC Berkeley loses CRISPR patent case, invalidating licenses it granted gene-editing companies
Ending the latest chapter in a years-long legal battle over who invented CRISPR, the U.S. Patent and Trademark Office ruled that the revolutionary genome editing technology belongs to the ...
COVID-19 vaccine and cancer – latest updates
Recently, news of a COVID-19 vaccine has dominated headlines. We've summarised all the information that is out there, with rolling updates, in our new vaccine blog post.
Biotech to Take Novel Cancer Drug to Market in H1/22
This biotech company is commercializing its lead drug candidate, Kimmtrak, has a catalyst-rich 2022, and has various clinical-stage drugs for cancers and autoimmune and infectious diseases.
Priothera Enters Loan Agreement of €17.5 Million with the European Investment Bank
This loan will further support a European, US and Asian registration-enabling clinical trial with mocravimod in Acute Myeloid Leukemia (AML) patients receiving hematopoietic stem …
Immutep Limited
Directors’ Report ................................................................................................................................................. 3 Auditor’s …
Drug Development and Lifecycle Management eLearning Program
Drug Development and Lifecycle Management eLearning Program
Could Novavax win over some religious vaccine skeptics?
Some abortion opponents have refused to get a coronavirus vaccine because of a distant link to fetal tissue in their development.
Navigating the Future of the MedTech Industry
The MedTech industry of the future will likely operate in a dramatically altered landscape. Forward-thinking organizations are evolving to address health care market and MedTech industry ...